Vetted study · Verified Sep 9, 2026

Redefine Study: COMP360 Psilocybin for PTSD

● Recruiting nowPsilocybinPTSD

Phase 2/3 trial testing whether COMP360 (a lab-made psilocybin formulation), given with therapist support, reduces PTSD symptoms. Open to the public; veterans with a PTSD diagnosis of 6+ months may qualify.

This is an interventional study — the research team administers the treatment under a controlled, IRB-approved protocol. Participation never happens outside that protocol.

★ Featured study

Microdosing Vets

Are you a combat veteran who's microdosed?

An Ethics Approved CIIS study documenting veterans' microdosing experience. Combat veterans 21–50 with a PTSD diagnosis and prior microdosing experience are needed.

5-Min Screening →

Substance: Psilocybin
Status: Recruiting now
Conditions: PTSD
Who can join: Adults 18+ diagnosed with PTSD for 6+ months
Where: Florida · New York
Run by: COMPASS Pathways
Registry ID: NCT07570654 ↗

Go to the official study page on ClinicalTrials.gov →

You enroll directly with the research team through their own official page and IRB-approved consent process. Psychedelic Vets does not run this study or collect any of your health information.

Why this listing is here. Every study in our directory is hand-reviewed against a published set of standards — recruiting or clearly marked, registered or run by a known institution, open to U.S. veterans, and research-only (never facilitation of obtaining any substance). See how we vet →

If you're in crisis, the Veterans Crisis Line is free, confidential, and available 24/7 — you don't have to be enrolled in VA care. Dial 988, then press 1, or text 838255.

Study data is sourced from ClinicalTrials.gov (U.S. National Library of Medicine) and verified university/nonprofit sources. This page is educational and is not medical advice or an endorsement. Details can change — always confirm on the official page above. ← Back to all studies